Immunologic reactivity of female patients with genital cancer: status in preinvasive, locally invasive, and disseminated disease.
D000328:Adult; D000368:Aged; D000917:Antibody Formation; D000937:Antigen-Antibody Reactions; D000942:Antigens, Bacterial; D000951:Antigens, Neoplasm; D002722:Chlorobenzenes; D003877:Dermatitis, Contact / Q000139:chemically induced / Q000276:immunology; D005260:Female; D005407:Flagella; D005833:Genital Neoplasms, Female / Q000276:immunology*; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007109:Immunity; D007111:Immunity, Cellular; D007158:Immunologic Techniques; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000097:blood / Q000276:immunology / Q000473:pathology; D012475:Salmonella / Q000276:immunology; D012882:Skin Tests; D002583:Uterine Cervical Neoplasms / Q000097:blood / Q000276:immunology / Q000473:pathology; D014594:Uterine Neoplasms / Q000097:blood / Q000276:immunology / Q000473:pathology
D000942:Antigens, Bacterial; D000951:Antigens, Neoplasm; D002722:Chlorobenzenes